David R. Rahn & Associates Inc. Eli Lilly & CO Transaction History
David R. Rahn & Associates Inc.
- $308 Million
- Q2 2024
A detailed history of David R. Rahn & Associates Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, David R. Rahn & Associates Inc. holds 5,612 shares of LLY stock, worth $5.07 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
5,612
Previous 5,600
0.21%
Holding current value
$5.07 Million
Previous $4.36 Million
16.62%
% of portfolio
1.65%
Previous 1.85%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
3,901Shares Held
765MCall Options Held
6.35MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$87.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$66.7 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.4 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30.6 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $859B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...